Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
AUTOR(ES)
Maki, Robert G.
FONTE
American Society of Clinical Oncology
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2716936Documentos Relacionados
- Capecitabine maintenance therapy in patients with recurrent or metastatic breast cancer
- Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer—Gynaecological Cancer Group)
- Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study – The UK ABC-01 Study
- Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor
- Phase II Study of High-Dose [131I]Metaiodobenzylguanidine Therapy for Patients With Metastatic Pheochromocytoma and Paraganglioma